产品供求
- 您当前位置:
- 首页
- 产品数据
- 4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1)
4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1)
4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1) 基本信息
- 中文名称:
- 4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1)
- 中文别名:
- 4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]morpholine,hydrochloride
- 英文名称:
- Morpholine,4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]-, hydrochloride(1:1)
- 英文别名:
- 4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]morpholine,hydrochloride;
Morpholine,4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)-,monohydrochloride;
4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride;
4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholine monohydrochloride
- CAS No.:
- 86871-73-0
- 分 子 式:
- C16H20ClN3O2.ClH
- 分 子 量:
- 0
- 精确分子量:
- 357.10100
- PSA:
- 50.38000
- 分子结构式:
-

- SDS:
- 查看
4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1) 物化性质
- 沸点:
- 502.3ºC at 760 mmHg
- 闪点:
- 257.6ºC
4-(2-{[5-(4-氯苯基)-4-甲基-1H-吡唑-3-基]氧基}乙基)吗啉盐酸盐(1:1) 毒理性
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- QE0479590
- CHEMICAL NAME :
- Morpholine,
4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)ox
y)ethyl)-, monohydrochloride
- CAS REGISTRY NUMBER :
- 86871-73-0
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C16-H20-Cl-N3-O2.Cl-H
- MOLECULAR WEIGHT :
- 358.30
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 125 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756